Neurology News and Research

Latest Neurology News and Research

REM sleep disorder: A sign of impending neurodegenerative disease

How many millions of people suffer from sleep disturbance? One sleep disorder in particular, called REM behavior disorder, could be a sign of impending neurodegenerative disease, including Parkinson's and dementia, say scientists presenting their research at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.

10 Jun 2014

Sleep may enhance memory formation

Sleep could play a major role in our ability to form long-term memories, suggest study findings.

9 Jun 2014

BP history affects late-life brain pathology

The relationship between late-life blood pressure and damage to the brain is modified by midlife hypertension history, research shows.

9 Jun 2014

International leaders redefine phenotypes of multiple sclerosis

Multiple sclerosis manifests itself in many different ways and different courses. A recent effort to fine-tune descriptions - or phenotypes -- of MS was undertaken by an international team of leaders in MS research and clinical care.

9 Jun 2014

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Valeant Pharmaceuticals International, Inc. today announced that that its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, received notice that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Jublia® (efinaconazole 10% topical solution), the first topical triazole approved for the treatment of onychomycosis of the toenails.

9 Jun 2014

Study defines how our ability to identify spatial acuity varies across the body

"Where does it hurt?" is the first question asked to any person in pain. A new UCL study defines for the first time how our ability to identify where it hurts, called "spatial acuity", varies across the body, being most sensitive at the forehead and fingertips.

9 Jun 2014

Healthy tissue grafted to brains of patients with Huntington's disease also develops signs of illness

A recent study published in Annals of Neurology reports that healthy human tissue grafted to the brains of patients with Huntington's disease in the hopes of treating the neurological disorder also developed signs of the illness, several years after the graft.

6 Jun 2014

Researchers examine how high blood pressure in middle age affects memory and thinking in old age

New research suggests that high blood pressure in middle age plays a critical role in whether blood pressure in old age may affect memory and thinking.

5 Jun 2014

New gene involved in Parkinson's disease, find researchers

A team of UCLA researchers has identified a new gene involved in Parkinson's disease, a finding that may one day provide a target for a new drug to prevent and potentially even cure the debilitating neurological disorder.

5 Jun 2014

Synthetic peptide carrier delivers drugs through blood-brain barrier for cancer treatment

Researchers at Mayo Clinic have demonstrated in a mouse model that their recently developed synthetic peptide carrier is a potential delivery vehicle for brain cancer chemotherapy drugs and other neurological medications. The findings appear in PLOS ONE.

4 Jun 2014

UAB launches personalized dementia risk assessment clinic

Neurologist David Geldmacher, M.D., who leads the University of Alabama at Birmingham memory disorders program, sees a lot of older patients with memory loss, dementia or Alzheimer's disease.

4 Jun 2014

BabySafe Project offers 10 steps to help pregnant women limit wireless radiation exposure

An international group of doctors and scientific experts is joining with non-profit organizations today to urge pregnant women to limit their exposure to wireless radiation from cell phones and other devices by taking simple steps to protect themselves and their unborn children.

4 Jun 2014

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.

3 Jun 2014

Hypertensive pregnant women who snore may have unrecognized obstructive sleep apnea

1 in 2 hypertensive pregnant women who habitually snore may have unrecognized obstructive sleep apnea, a sleeping disorder that can reduce blood oxygen levels during the night and that has been linked to serious health conditions, new University of Michigan-led research shows.

3 Jun 2014

Penn and Mayo Clinic researchers launch Seizure Detection Challenge

Researchers from Mayo Clinic and the University of Pennsylvania announce the launch of the Seizure Detection Challenge, an international competition inviting the best minds in "machine learning" to improve devices to track and treat epilepsy.

3 Jun 2014

NYU Langone scientists identify promising treatment target for Alzheimer's disease

Scientists at NYU Langone Medical Center have identified a compound, called 2-PMAP, in animal studies that reduced by more than half levels of amyloid proteins in the brain associated with Alzheimer's disease.

3 Jun 2014

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals plc today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a potential new treatment for the symptoms of excessive daytime sleepiness (EDS) in adults with narcolepsy.

3 Jun 2014

EHR solutions provider, ChartLogic, partners with Kareo

ChartLogic, a leader in electronic health record solutions for specialty and primary care physician practices, today announced a partnership with billing solutions powerhouse, Kareo, that will allow the company to offer its clients best-of-breed revenue cycle management.

2 Jun 2014

$Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma$

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

2 Jun 2014

Updated data from ImmunoCellular ICT-107 trial in patients with newly diagnosed GBM presented at ASCO 2014

ImmunoCellular Therapeutics, Ltd. announced that updated efficacy and safety data from the phase II trial of dendritic cell-based immunotherapeutic vaccine ICT-107 in patients with newly diagnosed glioblastoma multiforme (GBM) were presented at the 2014 American Society for Clinical Oncology (ASCO) annual meeting in Chicago.

2 Jun 2014

Neurology News and Research

Latest Neurology News and Research

REM sleep disorder: A sign of impending neurodegenerative disease

Sleep may enhance memory formation

BP history affects late-life brain pathology

International leaders redefine phenotypes of multiple sclerosis

Valeant Pharmaceuticals receives approval from FDA for treatment of onychomycosis

Study defines how our ability to identify spatial acuity varies across the body

Healthy tissue grafted to brains of patients with Huntington's disease also develops signs of illness

Researchers examine how high blood pressure in middle age affects memory and thinking in old age

New gene involved in Parkinson's disease, find researchers

Synthetic peptide carrier delivers drugs through blood-brain barrier for cancer treatment

UAB launches personalized dementia risk assessment clinic

BabySafe Project offers 10 steps to help pregnant women limit wireless radiation exposure

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Hypertensive pregnant women who snore may have unrecognized obstructive sleep apnea

Penn and Mayo Clinic researchers launch Seizure Detection Challenge

NYU Langone scientists identify promising treatment target for Alzheimer's disease

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

EHR solutions provider, ChartLogic, partners with Kareo

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Updated data from ImmunoCellular ICT-107 trial in patients with newly diagnosed GBM presented at ASCO 2014

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Neurology News and Research

Latest Neurology News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in